Does Rallies summarize COSM news?

Yes. Rallies summarizes COSM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.

Is COSM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COSM. It does not provide personalized investment advice.

COSM (Cosmos Holdings Inc. Common Stock) Stock Analysis - News

Cosmos Holdings Inc. Common Stock (COSM) is a publicly traded Healthcare sector company. As of May 21, 2026, COSM trades at $0.27 with a market cap of $15.37M and a P/E ratio of -0.45. COSM moved +0.00% today. Year to date, COSM is -46.43%; over the trailing twelve months it is -36.40%. Its 52-week range spans $0.28 to $1.32. Rallies surfaces COSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in COSM news today?

Cosmos Health Projects $3.2M U.S. Annual Revenue from Fort18 Launch: Cosmos Health expects Fort18 to generate over $3.2 million in incremental annual U.S. revenue within 12-18 months, launching commercially in June 2026 via direct-to-consumer e-commerce followed by selected retail expansion. The U.S. sexual health supplement market, valued at $965.8 million in 2023, is projected to reach $1.93 billion by 2030.

COSM Key Metrics

Key financial metrics for COSM
Metric	Value
Price	$0.27
Market Cap	$15.37M
P/E Ratio	-0.45
EPS	$-0.63
Dividend Yield	0.00%
52-Week High	$1.32
52-Week Low	$0.28
Volume	220.24K
Avg Volume	0
Revenue (TTM)	$65.27M
Net Income	$-19.14M
Gross Margin	12.10%

Latest COSM News

Cosmos Health Projects $3.2M U.S. Annual Revenue from Fort18 Launch — May 11, 2026
Cosmos Health Launches Fort18 After 5.1× Clinical Endurance Boost — May 6, 2026
Cosmos Health Forecasts Over $2.5M Annual Cur18 US Revenue Within 18 Months — Apr 30, 2026
Cosmos Health Launches 18 Series with Three Products Targeting $7.8B Market — Apr 21, 2026
Cosmos Health to Launch Liv18™ U.S. Production in April 2026 With $5M Revenue Forecast — Apr 20, 2026

Recent COSM Insider Trades

Siokas Grigorios bought 388.53K (~$145.00K) on Feb 12, 2026.
Siokas Grigorios bought 291.26K (~$120.00K) on Feb 11, 2026.
Siokas Grigorios bought 90.33K (~$45.00K) on Jan 23, 2026.

COSM Analyst Consensus

COSM analyst coverage data. Average price target: $0.00.

Common questions about COSM

What changed in COSM news today?: Cosmos Health Projects $3.2M U.S. Annual Revenue from Fort18 Launch: Cosmos Health expects Fort18 to generate over $3.2 million in incremental annual U.S. revenue within 12-18 months, launching commercially in June 2026 via direct-to-consumer e-commerce followed by selected retail expansion. The U.S. sexual health supplement market, valued at $965.8 million in 2023, is projected to reach $1.93 billion by 2030.
Does Rallies summarize COSM news?: Yes. Rallies summarizes COSM news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is COSM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COSM. It does not provide personalized investment advice.